About SIMMPYRA PHARMACEUTICALS, LLC
The company is a spin-off from Simmaron Research, focused on cutting-edge therapeutics for breast cancer, long COVID, and ME/CFS. It conducts research in neuroscience, cancer biology, and viral diseases.
Research in neuroscience and neurodegenerative diseases (Alzheimer's and Parkinson's)Development of therapeutics for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)Cancer biology research, including Triple-Negative Breast Cancer and Ovarian CancerLong-COVID research and detection of chronic inflammatory markersDrug discovery and synthesisBiochemistry and cell biology research
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to SIMMPYRA PHARMACEUTICALS, LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.